Overview

Effect of Inflammation on Pharmacokinetics of Posaconazole

Status:
Completed
Trial end date:
2017-08-01
Target enrollment:
0
Participant gender:
All
Summary
Posaconazole plasma concentration and inflammatory markers will be determined in all samples available from routine analysis.
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University Medical Center Groningen
Treatments:
Posaconazole
Criteria
Inclusion Criteria:

- >18 yrs

- receiving posaconazole

- Written informed consent

Exclusion Criteria:

- none